Impact of activating transcription factor 4 signaling on lipogenesis in HepG2 cells

Ren,Lu‑Ping; Yu,Xian; Song,Guang‑Yao; Zhang,Pu; Sun,Li‑Na; Chen,Shu‑Chun; Hu,Zhi‑Juan; Zhang,Xue‑Mei

doi:10.3892/mmr.2016.5453

Impact of activating transcription factor 4 signaling on lipogenesis in HepG2 cells

Authors:
- Lu‑Ping Ren
- Xian Yu
- Guang‑Yao Song
- Pu Zhang
- Li‑Na Sun
- Shu‑Chun Chen
- Zhi‑Juan Hu
- Xue‑Mei Zhang
View Affiliations

Affiliations: Department of Endocrinology and Metabolism, Hebei General Hospital, Shijiazhuang, Hebei 050051, P.R. China, Department of Nephrology, Hebei General Hospital, Shijiazhuang, Hebei 050051, P.R. China
Published online on: June 27, 2016 https://doi.org/10.3892/mmr.2016.5453
Pages: 1649-1658

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Non-alcoholic fatty liver disease (NAFLD) is a rapidly growing health threat that has previously been associated with lipogenesis. The direct effect of endoplasmic reticulum stress (ERS) inhibition on the induction of lipogenesis has not been investigated in hepatocytes in vitro. The impact of activating transcription factor‑4 (ATF4) on the lipogenic pathway and hepatic insulin transduction in liver cells also requires further investigation. In the present study, the triglyceride (TG) content of HepG2 cells stimulated with fructose was investigated using a commercially available enzymatic assay, and the expression levels of lipogenesis‑associated factors were determined by western blotting and reverse transcription‑quantitative polymerase chain reaction. Notably, the TG content of HepG2 cells was increased following incubation with fructose, which was accompanied by ERS. 4‑Phenylbutyric acid, an inhibitor of ERS, lowered the TG content by reducing the mRNA expression levels of sterol regulatory element‑binding protein 1 (SREBP‑1c) and carbohydrate‑responsive element‑binding protein (ChREBP), and the protein expression levels of fatty acid synthase (FAS), acetyl‑CoA carboxylase (ACC) and stearoyl‑CoA desaturase‑1 (SCD‑1). Conversely, tunicamycin, which is an inducer of ERS, increased the TG content and stimulated the expression of the above lipogeneic markers. ATF4 deficiency relieved TG accumulation and decreased the mRNA expression levels of SREBP‑1c and ChREBP, and protein expression levels of FAS, ACC and SCD‑1 in fructose‑treated HepG2 cells. Conversely, ATF4 overexpression increased the TG content by upregulating the mRNA expression levels of SREBP‑1c and ChREBP and protein expression levels of FAS, ACC and SCD‑1. Inhibition of ERS was shown to protect HepG2 cells against fructose‑induced TG accumulation, whereas induction of ERS stimulated hepatic lipogenesis. As a downstream transcription factor of the unfolded protein response, a deficiency in ATF4 attenuates fructose‑induced lipogenesis; while an overexpression of ATF4 can induce TG accumulation through stimulating hepatic lipogenesis. The results of the present study suggested that ATF4 may exert various physiological roles in lipid metabolism depending on the nutrient composition. In addition, these results suggested that ATF4 has a role in regulating lipogenesis and in the development of NAFLD; thus ATF4 may be considered a therapeutic target for NAFLD.

View Figures

View References

1	Malavolti M, Battistini NC, Miglioli L, Bagni I, Borelli L, Marino M, Scaglioni F and Bellentani S: Influence of lifestyle habits, nutritional status and insulin resistance in NAFLD. Front Biosci (Elite Ed). 4:1015–1023. 2012. View Article : Google Scholar
2	Firneisz G: Non-alcoholic fatty liver disease and type 2 diabetes mellitus: The liver disease of our age? World J Gastroenterol. 20:9072–9089. 2014.PubMed/NCBI
3	Leite NC, Villela-Nogueira CA, Cardoso CR and Salles GF: Non-alcoholic fatty liver disease and diabetes: From physiopathological interplay to diagnosis and treatment. World J Gastroenterol. 20:8377–8392. 2014. View Article : Google Scholar : PubMed/NCBI
4	Perry RJ, Samuel VT, Petersen KF and Shulman GI: The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. Nature. 510:84–91. 2014. View Article : Google Scholar : PubMed/NCBI
5	Ren LP, Chan SM, Zeng XY, Laybutt DR, Iseli TJ, Sun RQ, Kraegen EW, Cooney GJ, Turner N and Ye JM: Differing endoplasmic reticulum stress response to excess lipogenesis versus lipid oversupply in relation to hepatic steatosis and insulin resistance. PLoS One. 7:e308162012. View Article : Google Scholar : PubMed/NCBI
6	Ozcan U, Yilmaz E, Ozcan L, Furuhashi M, Vaillancourt E, Smith RO, Görgün CZ and Hotamisligil GS: Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science. 313:1137–1140. 2006. View Article : Google Scholar : PubMed/NCBI
7	Basseri S and Austin RC: Endoplasmic reticulum stress and lipid metabolism: Mechanisms and therapeutic potential. Biochem Res Int. 2012:8413622012. View Article : Google Scholar
8	Zhou H, Zhang K, Janciauskiene S and Li X: Endoplasmic reticulum stress and lipid metabolism. Biochem Res Int. 2012:2575282012. View Article : Google Scholar : PubMed/NCBI
9	Volmer R and Ron D: Lipid-dependent regulation of the unfolded protein response. Curr Opin Cell Biol. 33:67–73. 2015. View Article : Google Scholar :
10	Lee AH and Glimcher LH: Intersection of the unfolded protein response and hepatic lipid metabolism. Cell Mol Life Sci. 66:2835–2850. 2009. View Article : Google Scholar : PubMed/NCBI
11	Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, Ozdelen E, Tuncman G, Görgün C, Glimcher LH and Hotamisligil GS: Endoplasmic reticulum stress links obesity, insulin action and type 2 diabetes. Science. 306:457–461. 2004. View Article : Google Scholar : PubMed/NCBI
12	Ren LP, Song GY, Hu ZJ, Zhang M, Peng L, Chen SC, Wei L, Li F and Sun W: The chemical chaperon 4-phenylbutyric acid ameliorates hepatic steatosis through inhibition of de novo lipogenesis in high-fructose-fed rats. Int J Mol Med. 32:1029–1036. 2013.PubMed/NCBI
13	Oyadomari S, Harding HP, Zhang Y, Oyadomari M and Ron D: Dephosphorylation of translation initiation factor 2alpha enhances glucose tolerance and attenuates hepatosteatosis in mice. Cell Metab. 7:520–532. 2008. View Article : Google Scholar : PubMed/NCBI
14	Wang C, Huang Z, Du Y, Cheng Y, Chen S and Guo F: ATF4 regulates lipid metabolism and thermogenesis. Cell Res. 20:174–184. 2010. View Article : Google Scholar : PubMed/NCBI
15	Mohamed HA, Yao W, Fioravante D, Smolen PD and Byrne JH: cAMP-response elements in Aplysia creb1, creb2 and Ap-uch promoters: Implications for feedback loops modulating long term memory. J Biol Chem. 280:27035–27043. 2005. View Article : Google Scholar : PubMed/NCBI
16	Seo J, Fortuno ER III, Suh JM, Stenesen D, Tang W, Parks EJ, Adams CM, Townes T and Graff JM: Atf4 regulates obesity, glucose homeostasis and energy expenditure. Diabetes. 58:2565–2573. 2009. View Article : Google Scholar : PubMed/NCBI
17	Lange PS, Chavez JC, Pinto JT, Coppola G, Sun CW, Townes TM, Geschwind DH and Ratan RR: ATF4 is an oxidative stress-inducible, prodeath transcription factor in neurons in vitro and in vivo. J Exp Med. 205:1227–1242. 2008. View Article : Google Scholar : PubMed/NCBI
18	Li H, Meng Q, Xiao F, Chen S, Du Y, Yu J, Wang C and Guo F: ATF4 deficiency protects mice from high-carbohydrate-diet-induced liver steatosis. Biochem J. 438:283–289. 2011. View Article : Google Scholar : PubMed/NCBI
19	Xiao G, Zhang T, Yu S, Lee S, Calabuig-Navarro V, Yamauchi J, Ringquist S and Dong HH: ATF4 protein deficiency protects against high fructose-induced hypertriglyceridemia in mice.
20	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar J Biol Chem. 288:25350–25361. 2013. View Article : Google Scholar
21	Kammoun HL, Chabanon H, Hainault I, Luquet S, Magnan C, Koike T, Ferré P and Foufelle F: GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice. J Clin Invest. 119:1201–1215. 2009. View Article : Google Scholar : PubMed/NCBI
22	Zhang XQ, Xu CF, Yu CH, Chen WX and Li YM: Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol. 20:1768–1776. 2014. View Article : Google Scholar : PubMed/NCBI
23	Thorburn AW, Storlien LH, Jenkins AB, Khouri S and Kraegen EW: Fructose-induced in vivo insulin resistance and elevated plasma triglyceride levels in rats. Am J Clin Nutr. 49:1155–1163. 1989.PubMed/NCBI
24	Aragno M, Tomasinelli CE, Vercellinatto I, Catalano MG, Collino M, Fantozzi R, Danni O and Boccuzzi G: SREBP-1c in nonalcoholic fatty liver disease induced by Western-type high-fat diet plus fructose in rats. Free Radic Biol Med. 47:1067–1074. 2009. View Article : Google Scholar : PubMed/NCBI
25	Shimano H, Horton JD, Shimomura I, Hammer RE, Brown MS and Goldstein JL: Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. J Clin Invest. 99:846–854. 1997. View Article : Google Scholar : PubMed/NCBI
26	Denechaud PD, Bossard P, Lobaccaro JM, Millatt L, Staels B, Girard J and Postic C: ChREBP, but not LXRs, is required for the induction of glucose-regulated genes in mouse liver. J Clin Invest. 118:956–964. 2008.PubMed/NCBI
27	Malhi H and Kaufman RJ: Endoplasmic reticulum stress in liver disease. J Hepatol. 54:795–809. 2011. View Article : Google Scholar
28	Gentile CL, Frye M and Pagliassotti MJ: Endoplasmic reticulum stress and the unfolded protein response in nonalcoholic fatty liver disease. Antioxid Redox Signal. 15:505–521. 2011. View Article : Google Scholar :
29	Sha H, He Y, Chen H, Wang C, Zenno A, Shi H, Yang X, Zhang X and Qi L: The IRE1alpha-XBP1 pathway of the unfolded protein response is required for adipogenesis. Cell Metab. 9:556–564. 2009. View Article : Google Scholar : PubMed/NCBI
30	Sriburi R, Jackowski S, Mori K and Brewer JW: XBP1: A link between the unfolded protein response, lipid biosynthesis and biogenesis of the endoplasmic reticulum. J Cell Biol. 167:35–41. 2004. View Article : Google Scholar : PubMed/NCBI
31	Lee AH, Scapa EF, Cohen DE and Glimcher LH: Regulation of hepatic lipogenesis by the transcription factor XBP1. Science. 320:1492–1496. 2008. View Article : Google Scholar : PubMed/NCBI
32	Bobrovnikova-Marjon E, Hatzivassiliou G, Grigoriadou C, Romero M, Cavener DR, Thompson CB and Diehl JA: PERK-dependent regulation of lipogenesis during mouse mammary gland development and adipocyte differentiation. Proc Natl Acad Sci USA. 105:16314–16319. 2008. View Article : Google Scholar : PubMed/NCBI
33	Vallejo M, Ron D, Miller CP and Habener JF: C/ATF, a member of the activating transcription factor family of DNA-binding proteins, dimerizes with CAAT/enhancer-binding proteins and directs their binding to cAMP response elements. Proc Natl Acad Sci USA. 90:4679–4683. 1993. View Article : Google Scholar : PubMed/NCBI
34	Mamady H and Storey KB: Coping with the stress: Expression of ATF4, ATF6 and downstream targets in organs of hibernating ground squirrels. Arch Biochem Biophys. 477:77–85. 2008. View Article : Google Scholar : PubMed/NCBI
35	Wang C and Guo F: Effects of activating transcription factor 4 deficiency on carbohydrate and lipid metabolism in mammals. IUBMB Life. 64:226–230. 2012. View Article : Google Scholar : PubMed/NCBI